{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:07:37Z","timestamp":1788361657889,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059201"],"award-info":[{"award-number":["92059201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04192-0","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T19:02:12Z","timestamp":1709665332000},"page":"1653-1663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cox model risk score to predict survival of intrahepatic cholangiocarcinoma after ultrasound-guided ablation"],"prefix":"10.1007","volume":"49","author":[{"given":"Yueting","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"2","key":"4192_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL et al (2018) Cholangiocarcinoma-evolving concepts andtherapeutic strategies. Nature reviews. Clinical oncology, 15(2), 95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"3","key":"4192_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.suc.2020.02.013","volume":"100","author":"JC Mejia","year":"2020","unstructured":"Mejia JC, Pasko J (2020) Primary Liver Cancers: Intrahepatic Cholangiocarcinoma and H-epatocellular Carcinoma. The Surgical clinics of North America, 100(3), 535\u2013549. https:\/\/doi.org\/10.1016\/j.suc.2020.02.013","journal-title":"The Surgical Clinics of North America"},{"issue":"8","key":"4192_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ajg.2012.173","volume":"107","author":"JD Yang","year":"2012","unstructured":"Yang JD, Kim B, Sanderson SO et al (2012) Biliary tract cancers in Olmsted County, M-innesota, 1976 2008. The American journal of gastroenterology, 107(8), 1256\u20131262. https:\/\/doi.org\/10.1038\/ajg.2012.173","journal-title":"The American Journal of Gastroenterology"},{"issue":"2","key":"4192_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C et al (2023) Advances in the treatment of intrahepatic cholang-iocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA:a cancer journal for clinicians, 73(2), 198\u2013222. https:\/\/doi.org\/10.3322\/caac.21759","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"4192_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.suronc.2016.12.009","volume":"26","author":"AA Rahnemai-Azar","year":"2017","unstructured":"Rahnemai-Azar AA, Weisbrod A, Dillhoff M et al (2017) Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical oncology, 26(2), 125\u2013137. https:\/\/doi.org\/10.1016\/j.suronc.2016.12.009","journal-title":"Surgical Oncology"},{"issue":"3","key":"4192_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1245\/s10434-022-12833-1","volume":"30","author":"GD Ivey","year":"2023","unstructured":"Ivey GD, Hu C, He J (2023) Predicting Recurrence Patterns Following Curative-Intent Re-section for Intrahepatic Cholangiocarcinoma. Annals of surgical oncology, 30(3), 1282\u20131284. https:\/\/doi.org\/10.1245\/s10434-022-12833-1","journal-title":"Annals of Surgical Oncology"},{"issue":"6","key":"4192_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA et al (2014) Guidelines for the diagnosis and manage-ment of intrahepatic cholangiocarcinoma. Journal of hepatology, 60(6), 1268\u20131289. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.021","journal-title":"Journal of Hepatology"},{"issue":"1","key":"4192_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","volume":"8","author":"GM Shi","year":"2023","unstructured":"Shi, GM, Huang, XY, Wu, D et al (2023). Toripalimab combined with lenvatinib and GE-MOX is a promising regimen as first-line treatment for advanced intrahepatic cholangioc-arcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy, 8(1), 106. https:\/\/doi.org\/10.1038\/s41392-023-01317-7","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"4192_CR9","doi-asserted-by":"publisher","first-page":"1101038","DOI":"10.3389\/fonc.2023.1101038","volume":"13","author":"YQ Zhang","year":"2023","unstructured":"Zhang, YQ, Wang, K, Feng, JK et al (2023) Camrelizumab plus gemcitabine and oxalipl-atin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observati-onal retrospective study. Frontiers in oncology, 13, 1101038. https:\/\/doi.org\/10.3389\/fonc.2023.1101038","journal-title":"Frontiers in Oncology"},{"issue":"10391","key":"4192_CR10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"R Kelley","year":"2023","unstructured":"Kelley, R, Ueno, M, Yoo, C et al (2023) Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanc-ed biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England), 401(10391), 1853\u20131865. https:\/\/doi.org\/10.1016\/S0140-6736(23)00727-4","journal-title":"Lancet"},{"key":"4192_CR11","doi-asserted-by":"publisher","first-page":"175628482097697","DOI":"10.1177\/1756284820976974","volume":"13","author":"HT Liu","year":"2020","unstructured":"Liu HT, Cheng SB, Lai CY et al (2020) Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection. Therapeutic advances in gastroente-rology, 13, 1756284820976974. https:\/\/doi.org\/10.1177\/1756284820976974","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"2","key":"4192_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2214\/AJR.20.23461","volume":"217","author":"HH Chu","year":"2021","unstructured":"Chu HH, Kim JH, Shin YM et al (2021) Percutaneous Radiofrequency Ablation for Rec-urrent intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes. AJR. American journal of roentgenology, 217(2), 426\u2013432. https:\/\/doi.org\/10.2214\/AJR.20.23461","journal-title":"American Journal of Roentgenology"},{"issue":"3","key":"4192_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/02656736.2017.1327678","volume":"34","author":"K Zhang","year":"2018","unstructured":"Zhang K, Yu J, Yu X et al (2018) Clinical and survival outcomes of percutaneous micro-wave ablation for intrahepatic cholangiocarcinoma. International journal of hyperthermia, 34(3), 292\u2013297. https:\/\/doi.org\/10.1080\/02656736.2017.1327678","journal-title":"International Journal of Hyperthermia"},{"issue":"4","key":"4192_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.14218\/JCTH.2019.00036","volume":"7","author":"A Giorgio","year":"2019","unstructured":"Giorgio A, Gatti P, Montesarchio L et al (2019) Intrahepatic Cholangiocarcinoma and Th-ermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study. Journal of clinical and translational hepatology, 7(4), 287\u2013292. https:\/\/doi.org\/10.14218\/JCTH.2019.00036","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"1","key":"4192_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/02656736.2020.1763484","volume":"37","author":"G Brandi","year":"2020","unstructured":"Brandi G, Rizzo A, Dall\u2019Olio FG et al (2020) Percutaneous radiofrequency ablation in in-trahepatic cholangiocarcinoma: a retrospective single-center experience. International journal of hyperthermia, 37(1), 479\u2013485. https:\/\/doi.org\/10.1080\/02656736.2020.1763484","journal-title":"International Journal of Hyperthermia"},{"issue":"1","key":"4192_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardizatio-n of terminology and reporting criteria--a 10-year update. Radiology, 273(1), 241\u2013260. https:\/\/doi.org\/10.1148\/radiol.14132958","journal-title":"Radiology"},{"issue":"2","key":"4192_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaoncol.2019.4477","volume":"6","author":"Y Xia","year":"2020","unstructured":"Xia Y, Li J, Liu G et al (2020) Long-term Effects of Repeat Hepatectomy vs Percutaneo-us Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial. JAMA oncology, 6(2), 255\u2013263. https:\/\/doi.org\/10.1001\/jamaoncol.201 9.4477","journal-title":"JAMA Oncology"},{"issue":"10","key":"4192_CR18","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1634\/theoncologist.2018-0337","volume":"24","author":"F Izzo","year":"2019","unstructured":"Izzo F, Granata V, Grassi R et al (2019) Radiofrequency Ablation and Microwave Ablati-on in Liver Tumors: An Update. The oncologist, 24(10), e990\u2013e1005. https:\/\/doi.org\/10.1634\/theoncologist.2018-0337","journal-title":"The Oncologist"},{"issue":"11","key":"4192_CR19","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1245\/s10434-013-3035-1","volume":"20","author":"SJ Zhang","year":"2013","unstructured":"Zhang SJ, Hu P, Wang N et al (2013). Thermal ablation versus repeated hepatic resectionfor recurrent intrahepatic cholangiocarcinoma. Annals of surgical oncology, 20(11), 3596\u20133 602. https:\/\/doi.org\/10.1245\/s10434-013-3035-1","journal-title":"Annals of Surgical Oncology"},{"key":"4192_CR20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11454-y","author":"LQ Yao","year":"2022","unstructured":"Yao LQ, Chen ZL, Feng ZH et al (2022) Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Annals of surgical oncology. https:\/\/doi.org\/10.1245\/s10434-022-11454-y","journal-title":"Annals of Surgical Oncology"},{"issue":"7","key":"4192_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Bagante F et al (2018) Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. The British journal of surgery, 105(7), 848\u2013856. https:\/\/doi.org\/10.1002\/bjs.10676","journal-title":"The British Journal of Surgery"},{"issue":"1","key":"4192_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0168-8278(88)80463-x","volume":"6","author":"Y Okada","year":"1988","unstructured":"Okada Y, Jinno K, Moriwaki S et al (1988) Blood group antigens in the intrahepatic bili-ary tree. I. Distribution in the normal liver. Journal of hepatology, 6(1), 63\u201370. https:\/\/doi.org\/10.1016\/s0168-8278(88)80463-x","journal-title":"Journal of Hepatology"},{"issue":"2","key":"4192_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/hep.1840100209","volume":"10","author":"Y Nakanuma","year":"1989","unstructured":"Nakanuma Y, Sasaki M (1989) Expression of blood group-related antigens in the intrahep-atic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepat-ology (Baltimore, Md.), 10(2), 174\u2013178. https:\/\/doi.org\/10.1002\/hep.1840100209","journal-title":"Hepatology"},{"issue":"8","key":"4192_CR24","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1245\/s10434-020-08350-8","volume":"27","author":"A Moro","year":"2020","unstructured":"Moro A, Mehta R, Sahara K et al (2020) The Impact of Preoperative CA199 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma. Annals of surgical oncolo-gy, 27(8), 2888\u20132901. https:\/\/doi.org\/10.1245\/s10434-020-08350-8","journal-title":"Annals of Surgical Oncology"},{"issue":"17","key":"4192_CR25","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.7150\/jca.25339","volume":"9","author":"C He","year":"2018","unstructured":"He C, Zhang Y, Song Y et al (2018) Preoperative CEA levels are supplementary to CA1-99 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinom-a. Journal of Cancer, 9(17), 3117\u20133128. https:\/\/doi.org\/10.7150\/jca.25339","journal-title":"Journal of Cancer"},{"issue":"1","key":"4192_CR26","doi-asserted-by":"publisher","first-page":"e0267809","DOI":"10.1371\/journal.pone.0267809","volume":"18","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Hu Y, Ren Y et al (2023) Correlation between metastatic patterns and age in patients with metastatic primary liver cancer: A population-based study. PloS one, 18(1), e0267809. https:\/\/doi.org\/10.1371\/journal.pone.0267809","journal-title":"PloS One"},{"issue":"6","key":"4192_CR27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.ejso.2021.12.027","volume":"48","author":"LLY Tan","year":"2022","unstructured":"Tan LLY, Chew VTW, Syn N et al (2022) Effect of age on the short- and long-term out-comes of patients undergoing curative liver resection for HCC. European journal of surgic-aloncology, 48(6), 1339\u20131347. https:\/\/doi.org\/10.1016\/j.ejso.2021.12.027","journal-title":"European Journal of Surgical Oncology"},{"issue":"2","key":"4192_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT (2020) How the ageing microenvironment influences tumour pro-gression. Nature reviews. Cancer, 20(2), 89\u2013106. https:\/\/doi.org\/10.1038\/s41568-019-0222-9","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"4192_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jvir.2019.06.014","volume":"31","author":"\u00c1 D\u00edaz-Gonz\u00e1lez","year":"2020","unstructured":"D\u00edaz-Gonz\u00e1lez \u00c1, Vilana R, Bianchi L et al (2020) Thermal Ablation for Intrahepatic Ch-olangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients. Journal of va-scular and interventional radiology, 31(5), 710\u2013719. https:\/\/doi.org\/10.1016\/j.jvir.2019.06.014","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"11","key":"4192_CR30","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.21873\/anticanres.13808","volume":"39","author":"S Ohta","year":"2019","unstructured":"Ohta S, Morine Y, Imura S et al (2019) Carbohydrate Antigen 199 Is a Prognostic FactorWhich Correlates With HDAC1 and HIF-1\u03b1 for Intrahepatic Cholangiocarcinoma. Anticanc-er research, 39(11), 6025\u20136033. https:\/\/doi.org\/10.21873\/anticanres.13808","journal-title":"Anticancer Research"},{"issue":"1","key":"4192_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12957-018-1540-1","volume":"17","author":"C Wang","year":"2019","unstructured":"Wang C, Pang S, Si-Ma H et al (2019) Specific risk factors contributing to early and lat-e recurrences of intrahepatic cholangiocarcinoma after curative resection. World journal of surgical oncology, 17(1), 2. https:\/\/doi.org\/10.1186\/s12957-018-1540-1","journal-title":"World Journal of Surgical Oncology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04192-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:02:53Z","timestamp":1716267773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["4192"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04192-0","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflicts of interest that could influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}